中原證券(601375.SH)半年度淨利預增5.83倍-7.13倍
格隆匯7月16日丨中原證券(601375.SH)公吿,預計2021年半年度實現歸屬於上市公司股東的淨利潤同比增加17,994.22萬元到21,994.22萬元,同比增長583.27%-712.92%。
另外,預計2021年半年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤同比增加17,477.14萬元到21,477.14萬元,同比增長619.94%-761.83%。
2021年上半年,國內資本市場發展良好,公司積極把握市場機遇,主體業務穩健發展,投資銀行業務、證券投資業務、子公司業務等收入增加。預計2021年上半年公司實現合併利潤總額同比增加22,535.75萬元到27,869.08萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.